Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a post-hoc Analysis.
- DOI
- 10.3389/fmed.2022.897102
- Published
- 2022
- Container
- Frontiers in medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fmed.2022.897102,
title = {Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a post-hoc Analysis.},
author = {Molina-Molina M and Kreuter M and Cottin V and Corte TJ and Gilberg F and Kirchgaessler KU and Axmann J and Maher TM},
year = {2022},
journal = {Frontiers in medicine},
doi = {10.3389/fmed.2022.897102},
url = {https://doi.org/10.3389/fmed.2022.897102}
}RIS
TY - JOUR TI - Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a post-hoc Analysis. AU - Molina-Molina M AU - Kreuter M AU - Cottin V AU - Corte TJ AU - Gilberg F AU - Kirchgaessler KU AU - Axmann J AU - Maher TM PY - 2022 JO - Frontiers in medicine DO - 10.3389/fmed.2022.897102 UR - https://doi.org/10.3389/fmed.2022.897102 ER -
APA
M, M., M, K., V, C., TJ, C., F, G., KU, K., J, A., & TM, M. (2022). Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a post-hoc Analysis.. Frontiers in medicine. https://doi.org/10.3389/fmed.2022.897102
Source records
- pubmed · retrieved 2026-11-10T09:59:15.208Z